
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
APDN Granted US Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
February 25th, 2021
APDN to Provide COVID-19 Surveillance Testing to LIM College
February 19th, 2021
FY’21 Q1 Revenues at Upper End of Guided Range
February 11th, 2021
Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
February 11th, 2021
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
February 5th, 2021
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021
Will your cat need a COVID-19 vaccine?
January 28th, 2021
Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution
January 26th, 2021